Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:DSCSYOTCMKTS:KHNGYOTCMKTS:SSEZYOTCMKTS:SWTUY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDSCSYDisco$24.98+8.8%$20.61$16.10▼$42.93$27.08B1.23242,486 shs82,606 shsKHNGYKuehne + Nagel International$45.81+2.4%$45.29$39.53▼$62.83$27.66B0.9840,073 shs7,362 shsSSEZYSSE$22.78+0.2%$21.26$18.60▼$27.01$25.20B0.81193,742 shs56,184 shsSWTUYSWEDISH ORPHAN/S$24.38-1.2%$24.38$18.50▼$31.96$6.64B1.811,665 shs200 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDSCSYDisco+8.80%+24.00%+24.37%-16.43%-25.88%KHNGYKuehne + Nagel International+2.41%+3.07%+3.26%-1.72%-16.50%SSEZYSSE+0.22%-1.64%+8.32%+19.08%-2.86%SWTUYSWEDISH ORPHAN/S0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDSCSYDisco1.4358 of 5 stars0.05.01.70.00.00.01.9KHNGYKuehne + Nagel InternationalN/AN/AN/AN/AN/AN/AN/AN/ASSEZYSSE0.6036 of 5 stars0.03.01.70.01.50.00.6SWTUYSWEDISH ORPHAN/SN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDSCSYDisco 2.00HoldN/AN/AKHNGYKuehne + Nagel International 1.67ReduceN/AN/ASSEZYSSE 3.00BuyN/AN/ASWTUYSWEDISH ORPHAN/S 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SWTUY, KHNGY, SSEZY, and DSCSY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/27/2025SSEZYSSERoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform2/21/2025DSCSYDiscoNomura SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold(Data available from 5/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDSCSYDisco$2.13B12.71$0.53 per share46.74$2.77 per share9.02KHNGYKuehne + Nagel International$26.55B1.04$5.73 per share8.00N/A∞SSEZYSSE$13.14B1.92$3.60 per share6.32$13.57 per share1.68SWTUYSWEDISH ORPHAN/S$763.19M8.71$0.70 per share34.66$2.88 per share8.47Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDSCSYDisco$581.02M$0.7434.2230.10N/A32.04%28.36%20.71%N/AKHNGYKuehne + Nagel International$1.59B$2.2820.9219.83N/A4.83%37.72%10.11%7/22/2025 (Estimated)SSEZYSSE$2.24BN/A0.0011.221.29N/AN/AN/A5/21/2025 (Estimated)SWTUYSWEDISH ORPHAN/S$134.73M$0.5048.7616.931.3025.75%29.63%18.74%N/ALatest SWTUY, KHNGY, SSEZY, and DSCSY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/24/2025Q1 2025KHNGYKuehne + Nagel International$0.54$0.54N/A$0.54$5.73 billion$7.04 billion4/17/2025Q4 2025DSCSYDisco$0.20$0.23+$0.03$0.23$725.68 million$791.78 million3/3/2025Q4 2024KHNGYKuehne + Nagel International$0.61$0.57-$0.04$0.57$6.08 billion$7.70 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDSCSYDisco$0.100.40%N/A13.51%N/AKHNGYKuehne + Nagel International$1.232.69%N/A53.95%N/ASSEZYSSE$0.492.15%N/AN/AN/ASWTUYSWEDISH ORPHAN/SN/AN/AN/AN/AN/ALatest SWTUY, KHNGY, SSEZY, and DSCSY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2025KHNGYKuehne + Nagel International$1.23682.66%5/12/20255/13/20255/28/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDSCSYDiscoN/A2.621.76KHNGYKuehne + Nagel InternationalN/A0.920.92SSEZYSSE0.640.920.85SWTUYSWEDISH ORPHAN/SN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDSCSYDisco0.03%KHNGYKuehne + Nagel InternationalN/ASSEZYSSE0.22%SWTUYSWEDISH ORPHAN/SN/AInsider OwnershipCompanyInsider OwnershipDSCSYDiscoN/AKHNGYKuehne + Nagel InternationalN/ASSEZYSSEN/ASWTUYSWEDISH ORPHAN/SN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDSCSYDisco4,2601.08 billionN/ANot OptionableKHNGYKuehne + Nagel International80,983603.77 millionN/ANot OptionableSSEZYSSE14,9801.11 billionN/ANot OptionableSWTUYSWEDISH ORPHAN/S902272.51 millionN/ANot OptionableSWTUY, KHNGY, SSEZY, and DSCSY HeadlinesRecent News About These CompaniesEutelsat Group (OTCMKTS:EUTLF) & SWEDISH ORPHAN/S (OTCMKTS:SWTUY) Critical ContrastMay 5, 2025 | americanbankingnews.comBerenberg cuts SOBI stock target to SEK360, maintains buyApril 18, 2025 | uk.investing.comSobi announces a new research collaboration on the development of Gamifant in sepsis, which is to be presented at the ISICEM congressMarch 21, 2025 | pharmabiz.comRBC Capital Remains a Buy on Swedish Orphan Biovitrum AB (0MTD)January 14, 2025 | markets.businessinsider.comSobi Announces FDA Acceptance of New Drug Application for Avatrombopag (DOPTELET®) for the Treatment of Pediatric Immune ThrombocytopeniaDecember 12, 2024 | markets.businessinsider.comSobi North America Says SNDA Accepted For Avatrombopag In Paediatric Immune ThrombocytopeniaDecember 12, 2024 | markets.businessinsider.comLarger Study Supports Safety of Tetracyclines During Early PregnancyNovember 14, 2024 | medpagetoday.comSobi to present new data across its immunology portfolio at the ACR Convergence 2024November 7, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB: Sobi Q3 2024 report: Strong growth and significant pipeline momentumOctober 24, 2024 | finanznachrichten.deSobi Q3 2024 report: Strong growth and significant pipeline momentumOctober 24, 2024 | finance.yahoo.comMerck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In InfantsOctober 18, 2024 | benzinga.comMerck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17)October 18, 2024 | msn.comHigh Growth Tech Stocks In Sweden With Promising PotentialOctober 17, 2024 | finance.yahoo.comMerck's RSV antibody for infants shows over 60% efficacy in mid-late-stage studyOctober 17, 2024 | reuters.comThe Swedish Royal Family and Its Members, ExplainedOctober 9, 2024 | vogue.comExploring Sweden's High Growth Tech GiantsOctober 2, 2024 | uk.finance.yahoo.comNew Swedish law enables government funding for babysitting grandparentsSeptember 27, 2024 | yahoo.comEurope's CHMP turns down Apellis' pegcetacoplan appeal, endorses new drugs from Pfizer, ImmunoGen and HenliusSeptember 20, 2024 | fiercepharma.comLanguage in sexual offense judgments in Swedish courts makes victims responsibleSeptember 19, 2024 | msn.comThe Best Shows on Max Right Now (September 2024)September 15, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSWTUY, KHNGY, SSEZY, and DSCSY Company DescriptionsDisco OTCMKTS:DSCSY$24.98 +2.02 (+8.80%) As of 05/14/2025 03:59 PM EasternDisco Corporation manufactures and sells precision cutting, grinding, and polishing machines in Japan and internationally. Its precision machines include dicing saws, laser saws, grinders, polishers, wafer mounters, die separators, surface planers, and waterjet saws. The company also offers precision processing tools, such as dicing blades, grinding wheels, and dry polishing wheels; and other products, such as accessory equipment. In addition, it is involved in the disassembly and recycling of precision cutting, grinding, and polishing machines, as well as provides training services for the maintenance and operation of its products. Further, the company leases precision machines; and purchases and sells used machines. Additionally, it manufactures precision diamond abrasive tools, as well as offers chargeable processing services. The company was founded in 1937 and is headquartered in Tokyo, Japan.Kuehne + Nagel International OTCMKTS:KHNGY$45.81 +1.08 (+2.41%) As of 05/14/2025 03:50 PM EasternKuehne + Nagel International AG, together with its subsidiaries, provides integrated logistics services worldwide. The company operates through four segments: Sea Logistics, Air Logistics, Road Logistics, and Contract Logistics. It offers less-than-container load, reefer and project logistics, and flexible container shipping solutions. The company also provides time-critical solutions, sea-air and time-defined products, airside and air charter services, cargo insurance, and customs clearance services. In addition, it offers spare parts logistics, production, and e-commerce logistics, distribution, packaging, and process solutions. Further, the company provides supply chain consulting and order management services. It serves aerospace, automotive, mobility, consumer, healthcare, high-tech and semicon, industrial, and perishables industries. The company was founded in 1890 and is based in Schindellegi, Switzerland. Kuehne + Nagel International AG is a subsidiary of Kuehne Holding AG.SSE OTCMKTS:SSEZY$22.78 +0.05 (+0.22%) As of 05/14/2025 03:59 PM EasternSSE plc engages in the generation, transmission, distribution, and supply of electricity. It generates electricity from water, gas, coal, oil, and multi fuel. The company distributes electricity to approximately 3.8 million homes and businesses across the north of the central belt of Scotland and central southern England; and owns, operates, and develops high voltage electricity transmission system in the north of Scotland and remote islands. It also produces, stores, distributes, and supplies gas. In addition, it engages in the electricity and utility contracting, telecommunications, energy trading, insurance, and property holding businesses, as well as provides maintenance services. The company was formerly known as Scottish and Southern Energy plc and changed its name to SSE plc in September 2011. SSE plc was incorporated in 1989 and is based in Perth, the United Kingdom.SWEDISH ORPHAN/S OTCMKTS:SWTUY$24.38 -0.29 (-1.18%) As of 04/9/2019Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start AMD’s AI-Powered Stock Price Rally Just Shifted Gears Oklo Reaches Critical Mass, Atomic Upside Still Available Is Verizon a Buy? Q1 Results and Solid Dividend Make Bullish Case Carnival's Comeback: Is the Stock Set for a Profitable Journey? 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears U.S. Regulators Target CrowdStrike: Is It a Signal or Noise? Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
